Kyowa Kirin, Knight Therapeutics Enter Distribution Deal For POTELIGEO In Latin America

OTTAWA (dpa-AFX) - Tuesday, Kyowa Kirin (4151.T) said it entered into an exclusive distribution agreement with Knight Therapeutics (GUD.TO) for POTELIGEO (mogamulizumab) in select Latin American countries.Under the agreement, Knight will seek regulatory approvals and commercialize POTELIGEO for myc…